RACIBLESS Injection is a powerful anti-ulcer formulation designed to manage a wide range of acid-related gastrointestinal disorders. It works by selectively blocking H2 receptors in gastric parietal cells, effectively inhibiting basal, nocturnal, and food-stimulated acid secretion.

This injection helps reduce the volume and acidity of gastric juice, providing relief from heartburn, acid reflux, and peptic ulcers. It is also used in critical care for stress ulcer prophylaxis, aspiration prevention before anesthesia, and adjunctive management of upper GI bleeding.

RACIBLESS Injection is a trusted choice for healthcare professionals, ensuring rapid and reliable acid suppression in hospitalized or critically ill patients.

Key Benefits

• Provides fast and effective relief from gastric acidity and ulcers

• Controls excess acid secretion for longer duration

• Prevents reflux-related complications in GERD and esophagitis

• Reduces risk of stress ulcers in ICU or postoperative patients

• Aids in preventing aspiration pneumonitis before anesthesia

• Enhances healing of peptic and duodenal ulcers

How to Use

• RACIBLESS Injection should be administered only under medical supervision.

• Dosage and duration depend on the patient’s condition and medical advice.

• Administer via intravenous injection or infusion as prescribed by the physician.

Why Choose RACIBLESS Injection

• Provides consistent acid suppression with selective H2 receptor blocking

• Suitable for acute and critical care management

• Trusted formulation with proven safety and efficacy

• Recommended by healthcare professionals for GI disorder management

Ingredients / Composition

• Ranitidine Injection / H2 Receptor Blocker (active ingredient – as per brand formulation)